A new clinical trial, led by clinicians and researchers at the UNC School of Medicine, show that the combination of the drug vorinostat and immunotherapy may modestly shrink the latent HIV reservoir, but more work needs to be done in the field to create a cure.
In an effort five years in the making, UNC School of Medicine cell biologist Sarah Cohen, PhD, and Rockefeller University’s Ian Windham, PhD, describe the interplay between fats and proteins in brain cells and how their dysfunction contributes to the development of late-onset Alzheimer’s disease.
The UNC School of Medicine is on pace to become one of the few sites in the United States to incorporate intestinal ultrasound as an imaging technique for managing Inflammatory Bowel Disease.
Sydney and Sheridan Taylor of Durham, North Carolina, have lived with this rare genetic disorder all of their lives.
Chirag Desai, MD, FACS, an abdominal organ transplant and hepatobiliary-pancreatic surgeon at UNC Hospitals, performed a “domino” liver transplant, which helped two patients from a single donor without splitting a liver.
Catalina Berenblum Tobi, a 4th-year medical student, and Mara Buchbinder, PhD, professor and vice chair of social medicine at the UNC School of Medicine, recently published research about the words pediatricians use when describing inflammatory bowel disease to patients and how they affect patient perceptions of illness.
This research from UNC-Chapel Hill, published in the journal Nature Communications, opens the door to researching this wirelessly controlled patch to deliver on-demand treatments for neurodegenerative disorders, including Alzheimer’s disease.
Antibiotic overuse can lead to antibiotic resistance, a global health problem. But UNC School of Medicine scientists with Duke School of Medicine colleagues have documented another culprit in clinical antibiotic failure: bacterial persister cells.
Leslie B. Vosshall, PhD, the Robin Chemers Neustein Professor of Neurogenetics and Behavior at The Rockefeller University, will receive the Perl-UNC Neuroscience Prize for her work on receptors that drive host-seeking behavior in the mosquito.
Doctors at the UNC School of Medicine and Cincinnati Children’s collaborate to develop an innovative, patient-initiated online platform designed to remove the penicillin allergy label from misdiagnosed pediatric patients.
Researchers in the UNC School of Medicine’s Department of Psychiatry have found that enlarged perivascular spaces in the brains of babies, caused by an accumulation of excess cerebrospinal fluid, have a 2.2 times greater chance of developing autism later in life.
A new study led by Walker Redd, MD, at the UNC School of Medicine, examines how multiple factors contribute to the miscommunication and understanding of the digestive disease, microscopic colitis.
Research led by first and second authors Aaron C. Viser, Adelaide R. Cooke, and corresponding author Anne F. Peery, MD, associate professor of medicine at the UNC School of Medicine, reveals how a screening tool can measure the prevalence of malnutrition among patients at the UNC Multidisciplinary Inflammatory Bowel Disease Clinic.
The joint study between the UNC School of Medicine and the Orange County Health Department has been awarded a $21 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to make pregnancy and birth safer for North Carolinians with hypertensive disorders of pregnancy.
The clinical trial, led by Mirnela Byku, MD, PhD, MBA, at the UNC School of Medicine, found that excluding aspirin from the antithrombotic regimen in patients with a levitated left ventricular assist device is safe.
A new meta-analysis led by Micheal Sandbank, PhD, an assistant professor at the UNC School of Medicine, reveals a crucial need for more high-quality early intervention studies to help clinicians understand how to better support children diagnosed with the condition.
Susanna Stroik, PhD, and Dale Ramsden, PhD, in the Department of Biochemistry and Biophysics at the UNC School of Medicine, have learned more about an enzyme found to be overly expressed in patients with hereditary breast cancer, ovarian cancer, and prostate cancer.
Analyses led by Corinne Keet, MD, PhD, at the University of North Carolina School of Medicine, of two longitudinal studies reveal how an increased level of an antibody called immunoglobin (IgE) to cow’s milk is associated to cardiovascular-related death.
UNC Health is the only academic healthcare system in North Carolina and the South participating in the randomized trial, which aims to assess the safety and efficacy of a combination immunotherapy for newly diagnosed glioblastoma patients.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right